HER2-targeted therapies in cancer: a systematic review
Abstract Abnormal alterations in human epidermal growth factor receptor 2 (HER2, neu, and erbB2) are associated with the development of many tumors. It is currently a crucial treatment for multiple cancers. Advanced in molecular biology and further exploration of the HER2-mediated pathway have promo...
Saved in:
Main Authors: | Kunrui Zhu (Author), Xinyi Yang (Author), Hebei Tai (Author), Xiaorong Zhong (Author), Ting Luo (Author), Hong Zheng (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-world efficacy and safety of pyrotinib in patients with HER2-positive metastatic breast cancer: A prospective real-world study
by: Qiongwen Zhang, et al.
Published: (2023) -
HER2-targeted therapies for HER2-positive early-stage breast cancer: present and future
by: Luying Xu, et al.
Published: (2024) -
HER3 signaling and targeted therapy in cancer
by: Rosalin Mishra, et al.
Published: (2018) -
Photothermal Therapy with HER2-Targeted Silver Nanoparticles Leading to Cancer Remission
by: Victoria O. Shipunova, et al.
Published: (2022) -
Antibody-drug conjugates targeting HER2 for the treatment of urothelial carcinoma: potential therapies for HER2-positive urothelial carcinoma
by: Chia-Hsien Shih, et al.
Published: (2024)